Personalized medicine 2.0 – with the newly funded project „Patient Involvement in Oncology” (PATIO), the LBI Applied Diagnostics aims to create a platform for prostate cancer patients and affected persons that are involved in the illness. The goal of PATIO is to provide both information and support and to create a strong and unique […]
There are various tools to make science and related topics more approachable to the wider public. In general, science communication formats aim to inform, raise awareness, clarify misconceptions and inspire enthusiasm and excitement. Marie Niederleithinger, one of our institute’s PhD students, is especially interested in the dialog and discussion with her audience.
Congratulations to Assoc. Prof. Dr. Gerda Egger and Dr. Raheleh Sheibani from the Molecular Pathology program line of the LBI:AD! They received a FWF stand-alone grant for the project “The biological role of PSMA for prostate cancer”. The project focuses on the biological function of prostate specific membrane antigen (PSMA). Go and read more about […]
The MIC Festival of the Medical Imaging Cluster (MIC) of the Medical University of Vienna took place last week on June, 6th 2019. This year’s motto was Digital Revolution in Medical Imaging, highlighting the ever growing importance of big data, digitalization and computational analysis and their translation to clinical routine and research. Just as last […]
Thomas Dillinger, PhD student of our LBI’s Program Line Molecular Pathology, has spent two months with Boehringer Ingelheim in Vienna to gain insights into the research-driven pharmaceutical industry, to pick up on new laboratory techniques and to establish fruitful connections with new colleagues from various fields of expertise. His stay was funded thanks to a […]
Congratulations to Dr. med. univ. Johannes Längle to the Researcher of the Month Award! Fitting to this month’s Colorectal Cancer Awareness Campaign, the award was bestowed by the Medical University of Vienna on occasion of his recent publication about colorectal liver metastases and the implication of DNA damage with their prognosis and treatment response. The […]